Ideas

Managing glaucoma with branched chain amino acids: Branched chain amino acids increase Nmnat1 expression, increase NAD+ levels, improve neuronal dysfunction, and protect against glaucoma via down regulation of its target gene, 31/March/2018,  9.29 pm

Managing glaucoma with branched chain amino acids: Branched chain amino acids increase Nmnat1 expression, increase NAD+ levels, improve neuronal dysfunction, and protect against glaucoma via down regulation of its target gene, 31/March/2018,  9.29 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the The Jackson Laboratory, Bar Harbor, ME 04609, USA; Department of Ophthalmology, Tufts University of Medicine, Boston, MA 02111, USA; The Howard Hughes…

read more

A candy way to treat blood sugar disease: Sugar-based therapy for autoimmune diabetes (TIDM): Raffinose, a trisaccharide composed of galactose, glucose and fructose, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 31/March/2018, 12.15 am

A candy way to treat blood sugar disease: Sugar-based therapy for autoimmune diabetes (TIDM): Raffinose, a trisaccharide composed of galactose, glucose and fructose, increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 31/March/2018, 12.15 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and Clinical Sciences, University of…

read more

Managing heart diseases with essential amino acids:  Essential amino acid-based therapy for Cardiomyopathy: A therapeutic mix encompassing essential amino acids (10g) decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins and alleviates Cardiomyopathy via up regulation of its target gene, 31/March/2018, 12.01 am

Managing heart diseases with essential amino acids:  Essential amino acid-based therapy for Cardiomyopathy: A therapeutic mix encompassing essential amino acids (10g) decreases the expression of Sox6, restores the balance between slow- and fast-twitch myofiber proteins and alleviates Cardiomyopathy via up regulation of its target gene, 31/March/2018, 12.01 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say   A study from the Department of Cardiology, Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; and Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, USA shows that “Trbp regulates heart function through microRNA-mediated Sox6 repression.” This…

read more

Treating viral and bacterial diseases with statins: Statin-based anti-infective therapy: Lovastatin (trade name: Mevacor), a medication used in the treatment of lowering cholesterol, inhibits Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, Influenza H1NI1,  respiratory syncytial,  Sindbis, and SFV viruses by increasing the Levels of the Antiviral Proteins IFITM3, & Interferon-stimulated gene 15, 30/March/2018,  11.41 pm

Treating viral and bacterial diseases with statins: Statin-based anti-infective therapy: Lovastatin (trade name: Mevacor), a medication used in the treatment of lowering cholesterol, inhibits Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, Influenza H1NI1,  respiratory syncytial,  Sindbis, and SFV viruses by increasing the Levels of the Antiviral Proteins IFITM3, & Interferon-stimulated gene 15, 30/March/2018,  11.41 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A study from the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard Medical School, Charlestown, MA 02129, USA shows that “The IFITM proteins…

read more

Treat your heart ailments with longevity-promoting drugs: Carvedilol, a medication used in the treatment of congestive heart failure, left ventricular dysfunction and high blood pressure, may increase life span, via up-regulation of its target gene BubR1, 30/March/2018, 11.06 pm

Treat your heart ailments with longevity-promoting drugs: Carvedilol, a medication used in the treatment of congestive heart failure, left ventricular dysfunction and high blood pressure, may increase life span, via up-regulation of its target gene BubR1, 30/March/2018, 11.06 pm 960 720 Dr Boomi's Genom-2-Discovery Center

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School…

read more

A sweet way to protect your heart: Trisaccharide-based therapy for Myocardial Infarction: Raffinose, a trisaccharide composed of galactose, glucose, and fructose, inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up regulation of PNUTS, 30/March/2018, 10.54 pm

A sweet way to protect your heart: Trisaccharide-based therapy for Myocardial Infarction: Raffinose, a trisaccharide composed of galactose, glucose, and fructose, inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction, via up regulation of PNUTS, 30/March/2018, 10.54 pm 960 720 Dr Boomi's Genom-2-Discovery Center

What they say:  A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published, in the 7 March  2013 issue of of the journal Nature,  by Prof Dimmler,…

read more